PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $17,106,000 | -11.8% | 1,567,925 | +13.2% | 0.00% | -25.0% |
| Q3 2016 | $19,398,000 | +112.6% | 1,384,550 | +6.5% | 0.00% | +100.0% |
| Q2 2016 | $9,123,000 | +14.1% | 1,299,528 | +4.7% | 0.00% | 0.0% |
| Q1 2016 | $7,993,000 | -79.9% | 1,241,219 | +1.1% | 0.00% | -77.8% |
| Q4 2015 | $39,775,000 | +14.2% | 1,227,626 | -5.9% | 0.01% | 0.0% |
| Q3 2015 | $34,840,000 | -42.2% | 1,304,857 | +4.2% | 0.01% | -35.7% |
| Q2 2015 | $60,254,000 | -10.8% | 1,251,897 | +12.7% | 0.01% | -12.5% |
| Q1 2015 | $67,579,000 | +19.8% | 1,110,576 | +1.9% | 0.02% | +14.3% |
| Q4 2014 | $56,398,000 | +42.7% | 1,089,388 | +21.3% | 0.01% | +27.3% |
| Q3 2014 | $39,513,000 | +67.3% | 897,814 | -0.7% | 0.01% | +57.1% |
| Q2 2014 | $23,625,000 | +33.9% | 903,795 | +33.9% | 0.01% | +40.0% |
| Q1 2014 | $17,645,000 | +88.8% | 675,013 | +22.6% | 0.01% | +66.7% |
| Q4 2013 | $9,344,000 | +60.7% | 550,612 | +103.2% | 0.00% | +50.0% |
| Q3 2013 | $5,815,000 | – | 270,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |